The metabolomic window into hepatobiliary disease

Journal of Hepatology

Volumn 59, Issue 4, 2013, Pages 842-858

  Beyoǧlu, Diren ^a   Idle, Jeffrey R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cirrhosis; Core metabolomic phenotype; Hepatocellular carcinoma; Metabolic remodelling; Metabolomics; NAFLD; NASH; Warburg effect

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; AMMONIA; ATROLACTIC ACID; BETAINE; BILE ACID; BIOLOGICAL MARKER; CARNITINE; CELL NUCLEUS RECEPTOR; CHOLINE; CYTOCHROME P450 2E1; DEOXYCHOLIC ACID; GLUTAMIC ACID; GLYCOCHOLIC ACID; INDOLELACTIC ACID; LACTIC ACID; LACTIC ACID DERIVATIVE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A1; PHOSPHOLIPASE A2; PHOSPHOLIPID; PHOSPHORYLCHOLINE; TRIACYLGLYCEROL; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG;

ALCOHOL LIVER DISEASE; APOPTOSIS; BILE DUCT CARCINOMA; CHOLECYSTITIS; CHOLESTASIS; DISEASE COURSE; FATTY ACID OXIDATION; FATTY LIVER; GLUCOSE HOMEOSTASIS; GLYCOLYSIS; HEPATITIS B; HEPATITIS C; HEPATOBILIARY DISEASE; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; METABOLOMICS; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; TUMOR VIRUS; UPREGULATION; WILSON DISEASE;

CIRRHOSIS; CORE METABOLOMIC PHENOTYPE; HEPATOCELLULAR CARCINOMA; METABOLIC REMODELLING; METABOLOMICS; NAFLD; NASH; WARBURG EFFECT;

ANIMALS; BILE DUCT NEOPLASMS; BILIARY TRACT DISEASES; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CHOLECYSTITIS; CHOLESTASIS; DISEASE PROGRESSION; DRUG-INDUCED LIVER INJURY; FATTY LIVER; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; METABOLOMICS; MODELS, BIOLOGICAL;

EID: 84884414039     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.05.030     Document Type: Review

References (153)

1. J.R. Idle, and F.J. Gonzalez Metabolomics Cell Metab 6 2007 348 351 (Pubitemid 350012005)
2. G.C. Farrell, D. van Rooyen, L. Gan, and S. Chitturi NASH is an inflammatory disorder: pathogenic prognostic and therapeutic implications Gut Liver 6 2012 149 171
3. D.M. Torres, C.D. Williams, and S.A. Harrison Features, diagnosis, and treatment of non-alcoholic fatty liver disease Clin Gastroenterol Hepatol 10 2012 837 858
4. M. Vinaixa, M.A. Rodriguez, A. Rull, R. Beltran, C. Blade, and J. Brezmes Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease J Proteome Res 9 2010 2527 2538
5. V. van Ginneken, E. Verhey, R. Poelmann, R. Ramakers, K.W. van Dijk, and L. Ham Metabolomics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis Biochim Biophys Acta 1771 2007 1263 1270 (Pubitemid 47500220)
6. M.J. Hyde, J.L. Griffin, E. Herrera, C.D. Byrne, L. Clarke, and P.R. Kemp Delivery by Caesarean section, rather than vaginal delivery, promotes hepatic steatosis in piglets Clin Sci (Lond) 118 2010 47 59
7. P. Puri, M.M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, and H.K. Min The plasma lipidomic signature of non-alcoholic steatohepatitis Hepatology 50 2009 1827 1838
8. J.C. Garcia-Canaveras, M.T. Donato, J.V. Castell, and A. Lahoz A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations J Proteome Res 10 2011 4825 4834
9. S.C. Kalhan, L. Guo, J. Edmison, S. Dasarathy, A.J. McCullough, and R.W. Hanson Plasma metabolomic profile in non-alcoholic fatty liver disease Metabolism 60 2011 404 413
10. J. Barr, M. Vazquez-Chantada, C. Alonso, M. Perez-Cormenzana, R. Mayo, and A. Galan Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of non-alcoholic fatty liver disease J Proteome Res 9 2010 4501 4512
11. H. Li, L. Wang, X. Yan, Q. Liu, C. Yu, and H. Wei A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in non-alcoholic fatty liver disease J Proteome Res 10 2011 2797 2806
12. A.A. Toye, M.E. Dumas, C. Blancher, A.R. Rothwell, J.F. Fearnside, and S.P. Wilder Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice Diabetologia 50 2007 1867 1879 (Pubitemid 47222857)
13. Y. Noguchi, J.D. Young, J.O. Aleman, M.E. Hansen, J.K. Kelleher, and G. Stephanopoulos Tracking cellular metabolomics in lipoapoptosis- and steatosis-developing liver cells Mol Biosyst 7 2011 1409 1419
14. J.L. Griffin, J. Scott, and J.K. Nicholson The influence of pharmacogenetics on fatty liver disease in the Wistar and Kyoto rats: a combined transcriptomic and metabonomic study J Proteome Res 6 2007 54 61 (Pubitemid 46173658)
15. I.N. Hines, H.J. Hartwell, Y. Feng, E.J. Theve, G.A. Hall, and S. Hashway Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in AxB mice Am J Pathol 179 2011 2855 2865
16. J. Wei, K. Qiu de, and X. Ma Bile acids and insulin resistance: implications for treating non-alcoholic fatty liver disease J Dig Dis 10 2009 85 90
17. H. Wang, J. Chen, K. Hollister, L.C. Sowers, and B.M. Forman Endogenous bile acids are ligands for the nuclear receptor FXR/BAR Mol Cell 3 1999 543 553 (Pubitemid 29268438)
18. M.C. Stanton, S.C. Chen, J.V. Jackson, A. Rojas-Triana, D. Kinsley, and L. Cui Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice J Inflamm (Lond) 8 2011 8
19. D. Beyoglu, and J.R. Idle Metabolomics and its potential in drug development Biochem Pharmacol 85 2013 12 20
20. N. Tanaka, T. Matsubara, K.W. Krausz, A.D. Patterson, and F.J. Gonzalez Disruption of phospholipid and bile acid homeostasis in mice with non-alcoholic steatohepatitis Hepatology 56 2012 118 129
21. Y. Zhao, Y.Q. Chen, T.M. Bonacci, D.S. Bredt, S. Li, and W.R. Bensch Identification and characterization of a major liver lysophosphatidylcholine acyltransferase J Biol Chem 283 2008 8258 8265
22. M.A. Constantinou, S.E. Theocharis, and E. Mikros Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats Toxicol Appl Pharmacol 218 2007 11 19 (Pubitemid 46026839)
23. M.M. Yeh, and E.M. Brunt Pathology of non-alcoholic fatty liver disease Am J Clin Pathol 128 2007 837 847 (Pubitemid 350133997)
24. J. Wiegand, and T. Berg The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis Dtsch Arztebl Int 110 2013 85 91
25. X. Gou, Q. Tao, Q. Feng, J. Peng, S. Sun, and H. Cao Urinary metabonomics characterization of liver fibrosis induced by CCl(4) in rats and intervention effects of Xia Yu Xue Decoction J Pharm Biomed Anal 74 2013 62 65
26. A. Zhang, H. Sun, S. Dou, W. Sun, X. Wu, and P. Wang Metabolomics study on the hepatoprotective effect of scoparone using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry Analyst 138 2013 353 361
27. H. Gao, Q. Lu, X. Liu, H. Cong, L. Zhao, and H. Wang Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis Cancer Sci 100 2009 782 785
28. M.C. Waldhier, M.F. Almstetter, N. Nurnberger, M.A. Gruber, K. Dettmer, and P.J. Oefner Improved enantiomer resolution and quantification of free d-amino acids in serum and urine by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry J Chromatogr A 1218 2011 4537 4544
29. J.S. Lian, W. Liu, S.R. Hao, Y.Z. Guo, H.J. Huang, and D.Y. Chen A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry Chin Med J (Engl) 124 2011 1367 1373
30. Z. Du, L. Zhang, and S. Liu Application of liquid chromatography-mass spectrometry in the study of metabolic profiling of cirrhosis in different grades Se Pu 29 2011 314 319
31. S.W. Qi, Z.G. Tu, W.J. Peng, L.X. Wang, X. Ou-Yang, and A.J. Cai (1)H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis World J Gastroenterol 18 2012 285 290
32. X. Lin, Y. Zhang, G. Ye, X. Li, P. Yin, and Q. Ruan Classification and differential metabolite discovery of liver diseases based on plasma metabolic profiling and support vector machines J Sep Sci 34 2011 3029 3036
33. B. Martinez-Granados, J.M. Morales, J.M. Rodrigo, J. Del Olmo, M.A. Serra, and A. Ferrandez Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies Int J Mol Med 27 2011 111 117
34. H.J. Huang, A.Y. Zhang, H.C. Cao, H.F. Lu, B.H. Wang, and Q. Xie Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients Dig Liver Dis 2013 http://dx.doi.org/10.1016/j.dld.2013.01.001
35. S. Fukiya, M. Arata, H. Kawashima, D. Yoshida, M. Kaneko, and K. Minamida Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces FEMS Microbiol Lett 293 2009 263 270
36. J. Yang, G. Xu, Y. Zheng, H. Kong, T. Pang, and S. Lv Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases J Chromatogr B Analyt Technol Biomed Life Sci 813 2004 59 65 (Pubitemid 39535429)
37. J. Yang, G. Xu, Y. Zheng, H. Kong, C. Wang, and X. Zhao Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry J Chromatogr A 1084 2005 214 221 (Pubitemid 40966931)
38. Y. Yang, C. Li, X. Nie, X. Feng, W. Chen, and Y. Yue Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis J Proteome Res 6 2007 2605 2614 (Pubitemid 47122355)
39. P. Yin, D. Wan, C. Zhao, J. Chen, X. Zhao, and W. Wang A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry Mol Biosyst 5 2009 868 876
40. H. Wu, R. Xue, L. Dong, T. Liu, C. Deng, and H. Zeng Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry Anal Chim Acta 648 2009 98 104
41. J. Chen, W. Wang, S. Lv, P. Yin, X. Zhao, and X. Lu Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations Anal Chim Acta 650 2009 3 9
42. J. Wang, S. Zhang, Z. Li, J. Yang, C. Huang, and R. Liang (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis Tumour Biol 32 2011 223 231
43. T. Chen, G. Xie, X. Wang, J. Fan, Y. Qiu, and X. Zheng Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma Mol Cell Proteomics 5 2011 10:M110 004945
44. F. Chen, J. Xue, L. Zhou, S. Wu, and Z. Chen Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method Anal Bioanal Chem 401 2011 1899 1904
45. A.D. Patterson, O. Maurhofer, D. Beyoglu, C. Lanz, K.W. Krausz, and T. Pabst Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling Cancer Res 71 2011 6590 6600
46. Y. Tan, P. Yin, L. Tang, W. Xing, Q. Huang, and D. Cao Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis Mol Cell Proteomics 11 2012 M111 010694
47. B. Wang, D. Chen, Y. Chen, Z. Hu, M. Cao, and Q. Xie Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry J Proteome Res 11 2012 1217 1227
48. L. Zhou, Q. Wang, P. Yin, W. Xing, Z. Wu, and S. Chen Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases Anal Bioanal Chem 403 2012 203 213
49. G. Ye, B. Zhu, Z. Yao, P. Yin, X. Lu, and H. Kong Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry J Proteome Res 11 2012 4361 4372
50. X. Lin, F. Yang, L. Zhou, P. Yin, H. Kong, and W. Xing A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information J Chromatogr B Analyt Technol Biomed Life Sci 910 2012 149 155
51. H.W. Ressom, J.F. Xiao, L. Tuli, R.S. Varghese, B. Zhou, and T.H. Tsai Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis Anal Chim Acta 743 2012 90 100
52. J.F. Xiao, R.S. Varghese, B. Zhou, M.R. Nezami Ranjbar, Y. Zhao, and T.H. Tsai LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort J Proteome Res 11 2012 5914 5923
53. A. Zhang, H. Sun, G. Yan, Y. Han, Y. Ye, and X. Wang Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry Clin Chim Acta 418 2013 86 90
54. P. Nahon, R. Amathieu, M.N. Triba, N. Bouchemal, J.C. Nault, and M. Ziol Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis Clin Cancer Res 18 2012 6714 6722
55. A. Budhu, S. Roessler, X. Zhao, Z. Yu, M. Forgues, and J. Ji Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes Gastroenterology 2013
56. D. Beyoglu, S. Imbeaud, O. Maurhofer, P. Bioulac-Sage, J. Zucman-Rossi, and J.F. Dufour Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification Hepatology 58 2013 229 238
57. M.I. Shariff, A.I. Gomaa, I.J. Cox, M. Patel, H.R. Williams, and M.M. Crossey Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study J Proteome Res 10 2011 1828 1836
58. Z.F. Li, J. Wang, C. Huang, S. Zhang, J. Yang, and A. Jiang Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis Rapid Commun Mass Spectrom 24 2010 2765 2775
59. A.D. Southam, J.M. Easton, G.D. Stentiford, C. Ludwig, T.N. Arvanitis, and M.R. Viant Metabolic changes in flatfish hepatic tumours revealed by NMR-based metabolomics and metabolic correlation networks J Proteome Res 7 2008 5277 5285
60. G.D. Stentiford, M.R. Viant, D.G. Ward, P.J. Johnson, A. Martin, and W. Wenbin Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic study OMICS 9 2005 281 299 (Pubitemid 41446785)
61. D. Pessayre Role of mitochondria in non-alcoholic fatty liver disease J Gastroenterol Hepatol 22 2007 S20 27
62. M.M. Adeva, G. Souto, N. Blanco, and C. Donapetry Ammonium metabolism in humans Metabolism 61 2012 1495 1511
63. V. Felipo, A. Urios, E. Montesinos, I. Molina, M.L. Garcia-Torres, and M. Civera Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy Metab Brain Dis 27 2012 51 58
64. S. Mukherjee, K. Vaidyanathan, D.M. Vasudevan, and S.K. Das Role of plasma amino acids and gaba in alcoholic and non-alcoholic fatty liver disease-a pilot study Indian J Clin Biochem 25 2010 37 42
65. J.R. Seckl, and B.R. Walker Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action Endocrinology 142 2001 1371 1376 (Pubitemid 32299662)
66. M.S. Cooper, and P.M. Stewart 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation J Clin Endocrinol Metab 94 2009 4645 4654
67. S.S. Moon, Y.S. Lee, J.G. Kim, and I.K. Lee Association of 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms with serum alanine aminotransferase activity Diabetes Res Clin Pract 99 2013 343 350
68. D. Muting, and V. Wortmann Amino acid metabolism in liver diseases Dtsch Med Wochenschr 81 1956 1853 1856
69. G. Dam, P. Ott, N.K. Aagaard, and H. Vilstrup Branched-chain amino acids and muscle ammonia detoxification in cirrhosis Metab Brain Dis 28 2013 217 220
70. O. Warburg On respiratory impairment in cancer cells Science 124 1956 269 270
71. R.A. Cairns, I.S. Harris, and T.W. Mak Regulation of cancer cell metabolism Nat Rev Cancer 11 2011 85 95
72. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
73. A.M. Zivkovic, J. Bruce German, F. Esfandiari, and C.H. Halsted Quantitative lipid metabolomic changes in alcoholic micropigs with fatty liver disease Alcohol Clin Exp Res 33 2009 751 758
74. S. Li, H. Liu, Y. Jin, S. Lin, Z. Cai, and Y. Jiang Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice J Chromatogr B Analyt Technol Biomed Life Sci 879 2011 2369 2375
75. H. Fernando, K.K. Bhopale, S. Kondraganti, B.S. Kaphalia, and G.A. Shakeel Ansari Lipidomic changes in rat liver after long-term exposure to ethanol Toxicol Appl Pharmacol 255 2011 127 137
76. A.D. Patterson, O. Slanar, K.W. Krausz, F. Li, C.C. Hofer, and F. Perlik Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation J Proteome Res 8 2009 4293 4300
77. Y. Zhen, K.W. Krausz, C. Chen, J.R. Idle, and F.J. Gonzalez Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation Mol Endocrinol 21 2007 2136 2151 (Pubitemid 47347378)
78. S.K. Manna, A.D. Patterson, Q. Yang, K.W. Krausz, H. Li, and J.R. Idle Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse J Proteome Res 9 2010 4176 4188
79. S.K. Manna, A.D. Patterson, Q. Yang, K.W. Krausz, J.R. Idle, and A.J. Fornace UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model J Proteome Res 10 2011 4120 4133
80. C.S. Lieber Metabolism of alcohol Clin Liver Dis 9 2005 1 35 (Pubitemid 40341944)
81. X. Shi, D. Yao, and C. Chen Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis J Biol Chem 287 2012 6336 6349
82. L. Castera Noninvasive methods to assess liver disease in patients with hepatitis B or C Gastroenterology 142 2012 e1294
83. J. Yang, X. Zhao, X. Liu, C. Wang, P. Gao, and J. Wang High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B J Proteome Res 5 2006 554 561 (Pubitemid 43364095)
84. L. Zhang, X. Jia, X. Peng, Q. Ou, Z. Zhang, and C. Qiu Development and validation of a liquid chromatography-mass spectrometry metabonomic platform in human plasma of liver failure caused by hepatitis B virus Acta Biochim Biophys Sin (Shanghai) 42 2010 688 698
85. M. Sherman, S. Shafran, K. Burak, K. Doucette, W. Wong, and N. Girgrah Management of chronic hepatitis C: consensus guidelines Can J Gastroenterol 21 2007 25C 34C (Pubitemid 47177083)
86. M. Sherman, S. Shafran, K. Burak, K. Doucette, W. Wong, and N. Girgrah Management of chronic hepatitis B: consensus guidelines Can J Gastroenterol 21 2007 5C 24C (Pubitemid 47162250)
87. G.L. Davis, J.E. Albright, S.F. Cook, and D.M. Rosenberg Projecting future complications of chronic hepatitis C in the United States Liver Transpl 9 2003 331 338 (Pubitemid 36443043)
88. G.R. Lloyd, S. Ahmad, M. Wasim, and R.G. Brereton Pattern recognition of inductively coupled plasma atomic emission spectroscopy of human scalp hair for discriminating between healthy and hepatitis C patients Anal Chim Acta 649 2009 33 42
89. M. Sperling, and U. Karst Metallomics: an emerging interdisciplinary science Anal Bioanal Chem 405 2013 1789 1790
90. M.M. Godoy, E.P. Lopes, R.O. Silva, F. Hallwass, L.C. Koury, and I.M. Moura Hepatitis C virus infection diagnosis using metabonomics J Viral Hepat 17 2010 854 858
91. B. Roe, E. Kensicki, R. Mohney, and W.W. Hall Metabolomic profile of hepatitis C virus-infected hepatocytes PLoS One 6 2011 e23641
92. H. Sun, A. Zhang, G. Yan, C. Piao, W. Li, and C. Sun Metabolomic analysis of key regulatory metabolites in HCV-infected tree shrews Mol Cell Proteomics 12 2012 710 719
93. W.C. Palmer, and T. Patel Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma J Hepatol 57 2012 69 76
94. S.A. Khan, H.C. Thomas, B.R. Davidson, and S.D. Taylor-Robinson Cholangiocarcinoma Lancet 366 2005 1303 1314 (Pubitemid 41416587)
95. D. Komichi, S. Tazuma, T. Nishioka, H. Hyogo, and K. Chayama Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage Free Radic Biol Med 39 2005 1418 1427 (Pubitemid 41547222)
96. A.W. Sharif, H.R. Williams, T. Lampejo, S.A. Khan, D.S. Bansi, and D. Westaby Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy HPB (Oxford) 12 2010 396 402
97. M.S. Hashim Abdalla, S.D. Taylor-Robinson, A.W. Sharif, H.R. Williams, M.M. Crossey, and G.A. Badra Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma HPB (Oxford) 13 2011 385 390
98. K. Ishihara, N. Katsutani, N. Asai, A. Inomata, Y. Uemura, and A. Suganuma Identification of urinary biomarkers useful for distinguishing a difference in mechanism of toxicity in rat model of cholestasis Basic Clin Pharmacol Toxicol 105 2009 156 166
99. J.Y. Cho, T. Matsubara, D.W. Kang, S.H. Ahn, K.W. Krausz, and J.R. Idle Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge J Lipid Res 51 2010 1063 1074
100. M. Aoki, Y. Konya, T. Takagaki, K. Umemura, Y. Sogame, and T. Katsumata Metabolomic investigation of cholestasis in a rat model using ultra-performance liquid chromatography/tandem mass spectrometry Rapid Commun Mass Spectrom 25 2011 1847 1852
101. Z. Li, H. Shen, Y. Zhang, M. Lu, X. Qiao, and X. Meng Metabolomic study of serum from rabbits with acute acalculous cholecystitis Inflamm Res 61 2012 987 995
102. N.J. Serkova, Y. Zhang, J.L. Coatney, L. Hunter, M.E. Wachs, and C.U. Niemann Early detection of graft failure using the blood metabolic profile of a liver recipient Transplantation 83 2007 517 521 (Pubitemid 46667858)
103. P.A. Wilmarth, K.K. Short, O. Fiehn, S. Lutsenko, L.L. David, and J.L. Burkhead A systems approach implicates nuclear receptor targeting in the Atp7b(-/-) mouse model of Wilson's disease Metallomics 4 2012 660 668
104. E.M. Santos, J.S. Ball, T.D. Williams, H. Wu, F. Ortega, and R. van Aerle Identifying health impacts of exposure to copper using transcriptomics and metabolomics in a fish model Environ Sci Technol 44 2010 820 826
105. J. Trottier, A. Bialek, P. Caron, R.J. Straka, J. Heathcote, and P. Milkiewicz Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study Dig Liver Dis 44 2012 303 310
106. A. Sengupta, A. Basant, S. Ghosh, S. Sharma, and H.M. Sonawat Liver metabolic alterations and changes in host intercompartmental metabolic correlation during progression of malaria J Parasitol Res 2011 2011 901854
107. A. Sengupta, S. Ghosh, A. Basant, S. Malusare, P. Johri, and S. Pathak Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study Malar J 10 2011 384
108. S. Ghosh, A. Sengupta, S. Sharma, and H.M. Sonawat Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: a (1)H NMR spectroscopy-based metabonomic study J Proteome Res 11 2012 4992 5004
109. I. Barba, N. Chatauret, D. Garcia-Dorado, and J. Cordoba A 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats Liver Int 28 2008 1141 1148
110. H.R. Williams, I.J. Cox, and S.D. Taylor-Robinson Metabonomics in hepatic encephalopathy: lucidity emerging from confusion Liver Int 28 2008 1050 1051
111. B. Jimenez, C. Montoliu, D.A. MacIntyre, M.A. Serra, A. Wassel, and M. Jover Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance J Proteome Res 9 2010 5180 5187
112. J.S. Bajaj, P.M. Gillevet, N.R. Patel, V. Ahluwalia, J.M. Ridlon, and B. Kettenmann A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy Metab Brain Dis 27 2012 205 215
113. D.G. Robertson, M.D. Reily, R.E. Sigler, D.F. Wells, D.A. Paterson, and T.K. Braden Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants Toxicol Sci 57 2000 326 337
114. J.K. Nicholson, J. Connelly, J.C. Lindon, and E. Holmes Metabonomics: a platform for studying drug toxicity and gene function Nat Rev Drug Discov 1 2002 153 161 (Pubitemid 41646523)
115. Y. Wang, M.E. Bollard, H. Keun, H. Antti, O. Beckonert, and T.M. Ebbels Spectral editing and pattern recognition methods applied to high-resolution magic-angle spinning 1H nuclear magnetic resonance spectroscopy of liver tissues Anal Biochem 323 2003 26 32 (Pubitemid 37393354)
116. G.G. Harrigan, R.H. LaPlante, G.N. Cosma, G. Cockerell, R. Goodacre, and J.F. Maddox Application of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity Toxicol Lett 146 2004 197 205 (Pubitemid 37542395)
117. M.E. Bollard, H.C. Keun, O. Beckonert, T.M. Ebbels, H. Antti, and A.W. Nicholls Comparative metabonomics of differential hydrazine toxicity in the rat and mouse Toxicol Appl Pharmacol 204 2005 135 151 (Pubitemid 40432371)
118. W.H. Heijne, R.J. Lamers, P.J. van Bladeren, J.P. Groten, J.H. van Nesselrooij, and B. van Ommen Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis Toxicol Pathol 33 2005 425 433 (Pubitemid 40995481)
119. N.J. Waters, C.J. Waterfield, R.D. Farrant, E. Holmes, and J.K. Nicholson Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis J Proteome Res 5 2006 1448 1459 (Pubitemid 43865813)
120. A. Craig, J. Sidaway, E. Holmes, T. Orton, D. Jackson, and R. Rowlinson Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat J Proteome Res 5 2006 1586 1601 (Pubitemid 44036133)
121. K. Ishihara, N. Katsutani, and T. Aoki A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in rats Basic Clin Pharmacol Toxicol 99 2006 251 260 (Pubitemid 44289747)
122. B. Feng, S.M. Wu, S. Lv, F. Liu, H.S. Chen, and Y. Gao A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice BMC Gastroenterol 9 2009 99
123. M. Coen, F. Goldfain-Blanc, G. Rolland-Valognes, B. Walther, D.G. Robertson, and E. Holmes Pharmacometabonomic investigation of dynamic metabolic phenotypes associated with variability in response to galactosamine hepatotoxicity J Proteome Res 11 2012 2427 2440
124. I.K. Yap, T.A. Clayton, H. Tang, J.R. Everett, G. Hanton, and J.P. Provost An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate J Proteome Res 5 2006 2675 2684 (Pubitemid 44595169)
125. C. Shi, C.Q. Wu, A.M. Cao, H.Z. Sheng, X.Z. Yan, and M.Y. Liao NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats Toxicol Lett 173 2007 161 167 (Pubitemid 47391548)
126. J. Sun, L.K. Schnackenberg, R.D. Holland, T.C. Schmitt, G.H. Cantor, and Y.P. Dragan Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS J Chromatogr B Analyt Technol Biomed Life Sci 871 2008 328 340
127. C. Chen, K.W. Krausz, Y.M. Shah, J.R. Idle, and F.J. Gonzalez Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity Chem Res Toxicol 22 2009 699 707
128. J. Cheng, X. Ma, K.W. Krausz, J.R. Idle, and F.J. Gonzalez Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity Drug Metab Dispos 37 2009 1611 1621
129. J.H. Winnike, Z. Li, F.A. Wright, J.M. Macdonald, T.M. O'Connell, and P.B. Watkins Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans Clin Pharmacol Ther 88 2010 45 51
130. K. Fukuhara, A. Ohno, Y. Ando, T. Yamoto, and H. Okuda A 1H NMR-based metabolomics approach for mechanistic insight into acetaminophen-induced hepatotoxicity Drug Metab Pharmacokinet 26 2011 399 406
131. B.S. Kumar, B.C. Chung, O.S. Kwon, and B.H. Jung Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics J Appl Toxicol 32 2012 505 520
132. J.M. Prot, A. Bunescu, B. Elena-Herrmann, C. Aninat, L.C. Snouber, and L. Griscom Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury Toxicol Appl Pharmacol 259 2012 270 280
133. L. Shintu, R. Baudoin, V. Navratil, J.M. Prot, C. Pontoizeau, and M. Defernez Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs Anal Chem 84 2012 1840 1848
134. Y. Liao, S.Q. Peng, X.Z. Yan, and L.S. Zhang Metabonomics profile of urine from rats administrated with different treatment period of isoniazid Zhongguo Yi Xue Ke Xue Yuan Xue Bao 29 2007 730 737 (Pubitemid 351188188)
135. F. Li, J. Lu, J. Cheng, L. Wang, T. Matsubara, and I.L. Csanaky Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy Nat Med 19 2013 418 420
136. X. Huang, L. Shao, Y. Gong, Y. Mao, C. Liu, and H. Qu A metabonomic characterization of CCl4-induced acute liver failure using partial least square regression based on the GC/MS metabolic profiles of plasma in mice J Chromatogr B Analyt Technol Biomed Life Sci 870 2008 178 185
137. L. Yang, A. Xiong, Y. He, Z. Wang, C. Wang, and W. Li Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry Chem Res Toxicol 21 2008 2280 2288
138. Y. Lin, D. Si, Z. Zhang, and C. Liu An integrated metabonomic method for profiling of metabolic changes in carbon tetrachloride induced rat urine Toxicology 256 2009 191 200
139. L. Ding, F. Hao, Z. Shi, Y. Wang, H. Zhang, and H. Tang Systems biological responses to chronic perfluorododecanoic acid exposure by integrated metabonomic and transcriptomic studies J Proteome Res 8 2009 2882 2891
140. M.S. Lee, B.H. Jung, B.C. Chung, S.H. Cho, K.Y. Kim, and O.S. Kwon Metabolomics study with gas chromatography-mass spectrometry for predicting valproic acid-induced hepatotoxicity and discovery of novel biomarkers in rat urine Int J Toxicol 28 2009 392 404
141. Y. Liu, R. Huang, L. Liu, J. Peng, B. Xiao, and J. Yang Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy J Pharm Biomed Anal 52 2010 136 141
142. C. Sun, Y. Teng, G. Li, S. Yoshioka, J. Yokota, and M. Miyamura Metabonomics study of the protective effects of Lonicera japonica extract on acute liver injury in dimethylnitrosamine treated rats J Pharm Biomed Anal 53 2010 98 102
143. C. Lu, Y. Wang, Z. Sheng, G. Liu, Z. Fu, and J. Zhao NMR-based metabonomic analysis of the hepatotoxicity induced by combined exposure to PCBs and TCDD in rats Toxicol Appl Pharmacol 248 2010 178 184
144. X. Shi, B. Wahlang, X. Wei, X. Yin, K.C. Falkner, and R.A. Prough Metabolomic analysis of the effects of polychlorinated biphenyls in non-alcoholic fatty liver disease J Proteome Res 11 2012 3805 3815
145. N. Shima, I. Miyawaki, K. Bando, H. Horie, K. Zaitsu, and M. Katagi Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat Toxicology 287 2011 29 37
146. X. Lu, Q. Zhao, Y. Tian, S. Xiao, T. Jin, and X. Fan A metabonomic characterization of (+)-usnic acid-induced liver injury by gas chromatography-mass spectrometry-based metabolic profiling of the plasma and liver in rat Int J Toxicol 30 2011 478 491
147. T. Parman, D.I. Bunin, H.H. Ng, J.E. McDunn, J.E. Wulff, and A. Wang Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced
148. R.N. McBurney, W.M. Hines, L.S. Von Tungeln, L.K. Schnackenberg, R.D. Beger, and C.L. Moland The liver toxicity biomarker study: phase I design and preliminary results Toxicol Pathol 37 2009 52 64
149. P.B. Watkins Biomarkers for the diagnosis and management of drug-induced liver injury Semin Liver Dis 29 2009 393 399
150. R.D. Beger, J. Sun, and L.K. Schnackenberg Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity Toxicol Appl Pharmacol 243 2010 154 166
151. T.M. O'Connell, and P.B. Watkins The application of metabonomics to predict drug-induced liver injury Clin Pharmacol Ther 88 2010 394 399
152. H. Ellinger-Ziegelbauer, M. Adler, A. Amberg, A. Brandenburg, J.J. Callanan, and S. Connor The enhanced value of combining conventional and "omics" analyses in early assessment of drug-induced hepatobiliary injury Toxicol Appl Pharmacol 252 2011 97 111
153. E. Gonzalez, S. van Liempd, J. Conde-Vancells, V. Gutierrez-de Juan, M. Perez-Cormenzana, and R. Mayo Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity Metabolomics 8 2012 997 1011